Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Journal of Cosmetic Dermatology
|
July 19, 2023
Using 3% retinol peeling and cosmeceuticals for the aesthetic wellness of the oncological patient after precautionary endocrine treatment: A case series
M Belmontesi, C Noberasco
Tumori
|
March 1, 1995
Second-generation aromatase inhibitors
E Bajetta, N Zilembo, C Noberasco
Oncology Reports
|
May 21, 2011
Hormonal-therapy in patients with stage-iv breast-cancer at diagnosis
N Zilembo, E Bajetta, C Noberasco, et al.
Cancer Treatment Reviews
|
April 1, 1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy
E Bajetta, N Zilembo, R Buzzoni, et al.
Homeopathy : the Journal of the Faculty of Homeopathy
|
March 18, 2018
Integration of Homeopathy and Complementary Medicine in the Tuscan Public Health System and the Experience of the Homeopathic Clinic of the Lucca Hospital
E Rossi, M Di Stefano, M Picchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)
M Locatelli, M Colleoni, C Noberasco, et al.
Cancer Treatment Reviews
|
July 1, 1994
Hormone therapy in advanced breast carcinoma: present and future trends
E Bajetta, N Zilembo, A Di Leo, et al.
Oncology
|
November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancer
C Noberasco, E Bajetta, N Zilembo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1997
Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestane
A Martinetti, E Bajetta, E Seregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2009
Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration
T M De Pas, F Toffalorio, C Catania, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Journal of Cosmetic Dermatology
|
July 19, 2023
Using 3% retinol peeling and cosmeceuticals for the aesthetic wellness of the oncological patient after precautionary endocrine treatment: A case series
M Belmontesi, C Noberasco
Tumori
|
March 1, 1995
Second-generation aromatase inhibitors
E Bajetta, N Zilembo, C Noberasco
Oncology Reports
|
May 21, 2011
Hormonal-therapy in patients with stage-iv breast-cancer at diagnosis
N Zilembo, E Bajetta, C Noberasco, et al.
Cancer Treatment Reviews
|
April 1, 1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy
E Bajetta, N Zilembo, R Buzzoni, et al.
Homeopathy : the Journal of the Faculty of Homeopathy
|
March 18, 2018
Integration of Homeopathy and Complementary Medicine in the Tuscan Public Health System and the Experience of the Homeopathic Clinic of the Lucca Hospital
E Rossi, M Di Stefano, M Picchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Hepatic toxicity from cyclophosphamide, methotrexate, fluorouracil (CMF regimen)
M Locatelli, M Colleoni, C Noberasco, et al.
Cancer Treatment Reviews
|
July 1, 1994
Hormone therapy in advanced breast carcinoma: present and future trends
E Bajetta, N Zilembo, A Di Leo, et al.
Oncology
|
November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancer
C Noberasco, E Bajetta, N Zilembo, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1997
Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestane
A Martinetti, E Bajetta, E Seregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 20, 2009
Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration
T M De Pas, F Toffalorio, C Catania, et al.
Page
of 4